New Hampshire HB 1610: establishing the manufacturer pharmaceutical drug take-back program.

Status: Interim Study Report: Not Recommended for Future Legislation (Vote 19-0) (as of 2020-10-06)

State: New Hampshire · Session: 2020 · Bill: HB 1610

Sponsors: Tom J. Loughman, Gary Merchant, Jeb Bradley, Martha Fuller Clark, Rebecca Susan McBeath, Shannon E Chandley, Tom Sherman, William L. Fowler

View New Hampshire HB 1610 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.